iCAD
ICAD develops and delivers cancer detection and radiation therapy solutions, and services that enable clinicians to find and treat cancers.
Launch date
Employees
Market cap
€36.4m
Enterprise valuation
€18m (Public information from Sep 2024)
Share price
$1.56 ICAD
Nashua New Hampshire (HQ)
Authorizing premium user...